LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests a new approach for people with locally advanced stomach or gastroesophageal junction cancer. Before surgery, patients receive a combination of low-dose radiation, an immunotherapy drug (tirelizumab), and chemotherapy (SOX). The goal is to see if this treatment ca…
Matched conditions: LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug cocktail aims to shrink stomach tumors before surgery
Disease control Recruiting nowThis study tests whether adding a new immunotherapy combination (iparomlimab and tuvonralimab) to standard chemotherapy can better shrink locally advanced stomach or gastroesophageal junction cancer before surgery. About 96 adults with stage T3N+ or T4a cancer that hasn't spread …
Matched conditions: LOCALLY ADVANCED GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC